Replies to post #2309 on Filana Therapeutics Inc (FLNA)

[aCryptoKing]

BIOGEN'S Alzheimer's drug halted, "will NOT be administered", STOPPED IN IT's TRACKS yesterday:
https://www.fiercepharma.com/marketing/do-not-enter-biogen-reps-banned-from-d-c-area-neurology-clinics-over-controversial


Donepizil was NEVER this good (at the same stage) & they're having problems:

And we're BEST IN CLASS (compared to anyone else after Phase2 Trials):

[tootalljones]

great post and too, that avxl has a screening process, excluding, dinking and dunking, It gets a little complicated.....which is ok. I like the company. If SAVA goes to $250 in the next 8 months,or is bought out, very realistic by Pfizer or the other behemoths, as they now have 12 month data, which is guaranteed approval even now...let alone another quarter......
avxl will follow and see 35 to 40 bucks. Love both companies. I think somebody will buy SAVA and later AVXl.